Onasemnogene Abeparvovec Intrathecal Injection Set

Sole-source notice

Japanese title: オナセムノゲンアベパルボベク(髄注) 一式

Medical
About this page
This page is based on the official tender notice and presents information processed, translated, and edited by JBid.

Overview

This procurement notice announces a single tendering procedure for the purchase of one set of Onasemnogene Abeparvovec for intrathecal injection. The contract is planned to be awarded on October 23, 2026, by Tokai National Higher Education and Research System. The single tendering is justified by the protection of exclusive rights.

Key Details

  • Source: Kanpo
  • Notice type: Sole-source notice
  • Publication date: September 24, 2026
  • Procuring entity: Kiyokazu Nagao, Director of Tokai National Higher Education and Research System
  • Planned contract date: October 23, 2026
  • Intended vendor: Suzuken Co., Ltd.
  • Status: Active
  • Technology relevance: Possible
  • Business-action likelihood: Low – Single tendering due to exclusive rights and a sole named vendor limits business action opportunities.

Official Notice

Official Source

Kanpo, Japan's official government gazette, in which legally required public procurement notices are formally published.

  • Source: Kanpo, Government Procurement Notice Edition
  • Official category: Sole-source procurement notice
  • Publication date: September 24, 2026
  • Publication: Kanpo, pages 54

Full English Translation

The following English translation was prepared from the original Japanese notice published in Kanpo. Where an official English summary appears in the Kanpo publication, it was used only for verification; the translation below is based on the Japanese source text.

Notice of single tendering procedures as follows. Date: September 24, 2026. Tokai National Higher Education and Research System, Director Kiyokazu Nagao. Procurement agency number: 415. Location number: 23.
1. Procurement details
(1) Product classification number: 4
(2) Purchase subject and quantity: Onasemnogene Abeparvovec (intrathecal injection) one set.
2. Scheduled date of single tendering contract:
October 23, 2026.
3. Reason for single tendering under the Agreement on Government Procurement:
b Protection of exclusive rights.
4. Name of the party scheduled for single tendering contract:
Suzuken Co., Ltd.
5. Contact department:
Accounting Division, Nagoya University Hospital, Tokai National Higher Education and Research System, 65 Tsurumai-cho, Showa-ku, Nagoya City 464-8560. Procurement Group, Mika Inada. Phone: 052-744-2808.
Show original Japanese notice

随意契約に関する公示

次のとおり随意契約について公示します。令和8年9月24日国立大学法人東海国立大学機構機構長松尾清一◎調達機関番号415 ◎所在地番号23〇第3号-名古屋大学1 調達内容(1)品目分類番号　4(2)購入等件名及び数量　オナセムノゲンアベパルボベク(髄注) 一式2 随意契約の予定日　令和8年10月23日3 随意契約によることとする「政府調達に関する協定」の規定上の理由 b「排他的権利の保護」4 随意契約を予定している相手方の名称　株式会社スズケン5 担当部門 〒464-8560　名古屋市昭和区鶴舞町65国立大学法人東海国立大学機構名大病院事務部経理課調達グループ稲田美華　電話052-744-2808

Business Signal

Business Relevance

Use this notice for preparation or market research; it does not establish an open opportunity to submit a bid now.

  • Product fit: Potential
  • Current-case feasibility: Not applicable
  • Evidence confidence: Low
  • Supply-chain security: Unknown

Participation fit

This procedure is classified as sole-source and is not an open competitive tender. Direct participation is not applicable, but the notice may indicate existing government demand and active relevant vendors in Japan.

This page is based on the official Kanpo tender notice, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.

JBid is a beta technology-procurement intelligence service by I.J. Do.

Back to daily list